397 related articles for article (PubMed ID: 25630709)
1. Prevention of mother-to-child HIV-1 transmission in Burkina Faso: evaluation of vertical transmission by PCR, molecular characterization of subtypes and determination of antiretroviral drugs resistance.
Sagna T; Bisseye C; Compaore TR; Kagone TS; Djigma FW; Ouermi D; Pirkle CM; Zeba MT; Bazie VJ; Douamba Z; Moret R; Pietra V; Koama A; Gnoula C; Sia JD; Nikiema JB; Simpore J
Glob Health Action; 2015; 8():26065. PubMed ID: 25630709
[TBL] [Abstract][Full Text] [Related]
2. Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso.
Simpore J; Pietra V; Pignatelli S; Karou D; Nadembega WM; Ilboudo D; Ceccherini-Silberstein F; Ghilat-Avoid-Belem WN; Bellocchi MC; Saleri N; Sanou MJ; Ouedraogo CM; Nikiema JB; Colizzi V; Perno CP; Castelli F; Musumeci S
J Med Virol; 2007 Jul; 79(7):873-9. PubMed ID: 17516517
[TBL] [Abstract][Full Text] [Related]
3. Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso.
Nadembega WM; Giannella S; Simpore J; Ceccherini-Silberstein F; Pietra V; Bertoli A; Pignatelli S; Bellocchi MC; Nikiema JB; Cappelli G; Bere A; Colizzi V; Perno CP; Musumeci S
J Med Virol; 2006 Nov; 78(11):1385-91. PubMed ID: 16998878
[TBL] [Abstract][Full Text] [Related]
4. Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso.
Kouanda S; Tougri H; Cisse M; Simpore J; Pietra V; Doulougou B; Ouedraogo G; Ouedraogo CM; Soudre R; Sondo B
AIDS Care; 2010 Jul; 22(7):843-50. PubMed ID: 20635248
[TBL] [Abstract][Full Text] [Related]
5. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
Kowalska A; Niemiec T; El Midaoui A; Burkacka E
Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
[TBL] [Abstract][Full Text] [Related]
6. High rates of baseline antiretroviral resistance among HIV-infected pregnant women in an HIV referral centre in Rio de Janeiro, Brazil.
de Lourdes Teixeira M; Nafea S; Yeganeh N; Santos E; Gouvea MI; Joao E; Ceci L; Bressan C; Cruz ML; Sidi LC; Nielsen-Saines K
Int J STD AIDS; 2015 Nov; 26(13):922-8. PubMed ID: 25504831
[TBL] [Abstract][Full Text] [Related]
7. Efficiency of HAART in the prevention of mother to children HIV-1 transmission at Saint Camille medical centre in Burkina Faso, West Africa.
Linguissi LS; Bisseye C; Sagna T; Nagalo BM; Ouermi D; Djigma FW; Pignatelli S; Sia JD; Pietra V; Moret R; Nikiema JB; Simpore J
Asian Pac J Trop Med; 2012 Dec; 5(12):991-4. PubMed ID: 23199720
[TBL] [Abstract][Full Text] [Related]
8. HIV drug resistance pattern among HAART-exposed patients with suboptimal virological response in Ouagadougou, Burkina Faso.
Tebit DM; Sangaré L; Makamtse A; Yameogo S; Somlare H; Bado G; Kouldiaty BG; Sathiandee K; Tiba F; Sanou I; Ouédraogo-Traoré R; Zoungrana L; Diallo I; Drabo JY; Kräusslich HG
J Acquir Immune Defic Syndr; 2008 Sep; 49(1):17-25. PubMed ID: 18667925
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of antiretroviral therapy on mother to child transmission HIV in HIV-1 positive pregnant women: case of St. Camillus Medical Center in Ouagadougou, Burkina Faso].
Soubeiga ST; Compaore R; Djigma F; Zagre N; Assengone E; Traore L; Diarra B; Bisseye C; Ouermi D; Sagna T; Karou S; Pietra V; Simpore J
Pan Afr Med J; 2015; 20():399. PubMed ID: 26301003
[TBL] [Abstract][Full Text] [Related]
10. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 mother-to-child transmission and drug resistance among Brazilian pregnant women with high access to diagnosis and prophylactic measures.
Alcântara KC; Lins JB; Albuquerque M; Aires LM; Cardoso LP; Minuzzi AL; Stefani MM
J Clin Virol; 2012 May; 54(1):15-20. PubMed ID: 22317908
[TBL] [Abstract][Full Text] [Related]
12. Characterization of HIV-1 genotypes and antiretroviral drug-resistance mutations among patients in Burkina Faso.
Kagone TS; Hien H; Meda N; Diagbouga PS; Sawadogo A; Drabo J; Peeters M; Vergne L; Delaporte E; De Souza C; Gbeassor M; Simpore J
Pak J Biol Sci; 2011 Mar; 14(6):392-8. PubMed ID: 21902063
[TBL] [Abstract][Full Text] [Related]
13. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
Palombi L; Marazzi MC; Voetberg A; Magid NA
AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 infection and pregnancy in young women in Brazil: socioeconomic and drug resistance profiles in a cross-sectional study.
Lima YA; Reis MN; Cardoso LP; Stefani MM
BMJ Open; 2016 Jul; 6(7):e010837. PubMed ID: 27381205
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis.
Zeh C; Weidle PJ; Nafisa L; Lwamba HM; Okonji J; Anyango E; Bondo P; Masaba R; Fowler MG; Nkengasong JN; Thigpen MC; Thomas T
PLoS Med; 2011 Mar; 8(3):e1000430. PubMed ID: 21468304
[TBL] [Abstract][Full Text] [Related]
16. Mother-to-child HIV and HHV-8 transmission in neonates at Saint Camille Medical Centre in Burkina Faso.
Ilboudo D; Simpore J; Sanou DS; Karou D; Sia DJ; Ouermi D; Bisseye C; Sagna T; Odolini S; Buelli F; Pietra V; Pignatelli S; Gnoula C; Nikiema JB; Castelli F
Pak J Biol Sci; 2009 Jun; 12(12):908-13. PubMed ID: 19777784
[TBL] [Abstract][Full Text] [Related]
17. Genotypic resistance tests for the management of the HIV-infected pregnant woman.
Bassetti D; Cargnel A
Scand J Infect Dis Suppl; 2003; 106():70-4. PubMed ID: 15000589
[TBL] [Abstract][Full Text] [Related]
18. Emergence of lamivudine resistance hepatitis B virus mutations in pregnant women infected with HBV and HIV receiving antiretroviral prophylaxis for the prevention of mother-to-infant transmission in Malawi.
Galluzzo C; Liotta G; Andreotti M; Luhanga R; Jere H; Mancinelli S; Maulidi M; Sagno JB; Pirillo M; Erba F; Amici R; Ceffa S; Marazzi MC; Vella S; Palombi L; Giuliano M
J Med Virol; 2012 Oct; 84(10):1553-7. PubMed ID: 22930502
[TBL] [Abstract][Full Text] [Related]
19. Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy.
Kakehasi FM; Tupinambás U; Cleto S; Aleixo A; Lin E; Melo VH; Aguiar RA; Pinto JA
AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1515-20. PubMed ID: 18160009
[TBL] [Abstract][Full Text] [Related]
20. Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.
Schwartz SR; Kumwenda N; Kumwenda J; Chen S; Mofenson LM; Taylor AW; Fowler MG; Taha TE
Matern Child Health J; 2016 Mar; 20(3):542-9. PubMed ID: 26525557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
